ConductScience.org, home

Paper8093668

P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.

Grogan TM and 7 others. Blood, 1993. Cited by 191 papers, by iCite.

Cite this record

ConductScience Library. P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Papers, record 8093668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093668

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
PubMed
Journal
Blood
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
191
iCite
Relative citation ratio, by iCite
4.98
iCite
Revised in PubMed
2021-02-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grogan TMT M
2Spier CMC M
3Salmon SES E
4Matzner MM
5Rybski JJ
6Weinstein RSR S
7Scheper RJR J
8Dalton WSW S

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone MarrowMajor topic
DoxorubicinMajor topic
Membrane GlycoproteinsMajor topic
Multiple MyelomaMajor topic
VincristineMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Antibodies, Monoclonal
Antigens, CD
Biopsy
Dose-Response Relationship, Drug
Drug Resistance
Female
Humans
Immunohistochemistry
Immunophenotyping
Male
Middle Aged
Neoplasm Staging
Regression Analysis

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-17094NCI NIH HHSUnited StatesP01CA017094PubMed and NIHNIH RePORTER
CA-23074NCI NIH HHSUnited StatesP30CA023074PubMed and NIHNIH RePORTER
CA-43043NCI NIH HHSUnited StatesR01CA043043PubMed and NIHNIH RePORTER
R23CA043043NIHNIH RePORTER
R29CA043043NIHNIH RePORTER

Download CSV of grants

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.

PMIDTitleJournalYearIn PapersSource
37686623Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response.Cancers (Basel)2023https://conductscience.org/library/papers/37686623PubMed
36678608Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/36678608PubMed
36325145P-glycoprotein and cancer: what do we currently know?Heliyon2022https://conductscience.org/library/papers/36325145PubMed
35582143Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.Cancer Drug Resist2019https://conductscience.org/library/papers/35582143PubMed
35163567Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment.Int J Mol Sci2022https://conductscience.org/library/papers/35163567PubMed
34478517Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.Blood Adv2021https://conductscience.org/library/papers/34478517PubMed
34151200Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma.ACS Pharmacol Transl Sci2021https://conductscience.org/library/papers/34151200PubMed
33860196Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells.ACS Pharmacol Transl Sci2021https://conductscience.org/library/papers/33860196PubMed
33543229Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers.Biosci Rep2021https://conductscience.org/library/papers/33543229PubMed
33053111P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up.Braz J Med Biol Res2020https://conductscience.org/library/papers/33053111PubMed
32170169A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma.Blood Cancer J2020https://conductscience.org/library/papers/32170169PubMed
32050631Multiple Myeloma: Available Therapies and Causes of Drug Resistance.Cancers (Basel)2020https://conductscience.org/library/papers/32050631PubMed
31620167Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma.Front Genet2019https://conductscience.org/library/papers/31620167PubMed
31121280Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors.J Control Release2019https://conductscience.org/library/papers/31121280PubMed
30140376STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models.Oncotarget2018https://conductscience.org/library/papers/30140376PubMed
29766327Characterization of carfilzomib-resistant non-small cell lung cancer cell lines.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/29766327PubMed
29181307Expression of multidrug resistance proteins in retinoblastoma.Int J Ophthalmol2017https://conductscience.org/library/papers/29181307PubMed
28509582Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.Leuk Lymphoma2017https://conductscience.org/library/papers/28509582PubMed
28203307Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.Clin Epigenetics2017https://conductscience.org/library/papers/28203307PubMed
27648351Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?Am J Cancer Res2016https://conductscience.org/library/papers/27648351PubMed

See all 53 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8093668

GET https://conductscience.org/api/papers/v1/8093668/cited_by?page=2